Neogen Corporation (NEOG) Bundle
A Brief History of Neogen Corporation (NEOG)
Foundation and Early Years
Neogen Corporation was founded in 1982 by Dr. Norman A. Schuetz and his partner, Dr. John M. A. Smith. The company was incorporated in Michigan and started its operations focusing on food safety and animal health products.
Initial Public Offering and Growth
In 1996, Neogen Corporation went public, trading on the NASDAQ under the ticker symbol NEOG. The initial share price was $8.50. Over the years, the company's stock price demonstrated significant growth.
Acquisitions and Expansion
Neogen has strategically acquired multiple companies to bolster its product offerings. Notable acquisitions include:
- In 2007, Neogen acquired GeneSeek, expanding its capabilities in genomics.
- In 2016, Neogen acquired Gordon’s, enhancing its portfolio in animal health products.
- In 2020, Neogen acquired SureFood, which worked to strengthen its position in food safety testing.
Recent Financial Performance
As of the fiscal year ending May 31, 2023, Neogen reported the following financial metrics:
| Metric | Value |
|---|---|
| Revenue | $532 million |
| Net Income | $56 million |
| Operating Income | $73 million |
| Total Assets | $900 million |
| Total Equity | $525 million |
Product Development and Innovation
Neogen is renowned for its innovative products in food safety and animal health. Their product lines include:
- Food Safety: Diagnostics for pathogens, allergens, and toxins, with over 500 products in this category.
- Animal Safety: Products for the health and wellness of livestock and companion animals, including vaccines and diagnostics.
Market Presence
Neogen operates globally, with sales in over 100 countries. Its presence is particularly strong in:
- North America
- Europe
- Asia-Pacific
Stock Performance
As of October 2023, the stock price of Neogen Corporation was $37.12, reflecting a market capitalization of approximately $2.4 billion. Over the past year, the stock price had fluctuated, with a 52-week high of $56.18 and a low of $36.34.
Future Outlook
Neogen has indicated plans for ongoing growth through research and development investments, aiming to expand its product offerings in both food safety and animal health sectors. The projected growth rate for the food safety market is estimated at 6.7% annually through 2025.
Sustainability Initiatives
Neogen is also committed to sustainability, with initiatives aimed at reducing waste and energy usage in its operations. In recent years, the company has reported a 20% reduction in greenhouse gas emissions relative to total sales since 2018.
Conclusion
Neogen Corporation continues to demonstrate resilience and adaptability in the ever-evolving sectors of food safety and animal health. With a solid financial foundation, innovative products, and a commitment to sustainability, Neogen is well-positioned for future growth.
A Who Owns Neogen Corporation (NEOG)
Current Ownership Structure
Current Ownership Structure
As of the latest available data, Neogen Corporation (NEOG) has several significant shareholders. The ownership is divided among institutional investors, individual stakeholders, and insiders.
| Shareholder Type | Percentage Owned | Number of Shares | Market Value (approx.) |
|---|---|---|---|
| Institutional Investors | 95.8% | 41,500,000 | $1.2 billion |
| Insider Ownership | 4.2% | 1,700,000 | $50 million |
| Individual Investors | 0% | 0 | $0 |
Top Institutional Shareholders
The largest institutional stakeholders include a range of investment firms. Here are the top five as of the latest reporting:
| Institution | Percentage of Total Shares | Shares Held | Value of Holdings (approx.) |
|---|---|---|---|
| The Vanguard Group | 9.9% | 4,250,000 | $120 million |
| BlackRock, Inc. | 9.1% | 3,850,000 | $110 million |
| State Street Corporation | 7.4% | 3,150,000 | $90 million |
| AllianceBernstein | 5.8% | 2,450,000 | $70 million |
| Dimensional Fund Advisors | 4.3% | 1,850,000 | $53 million |
Insider Ownership Details
Insider holdings provide insight into the confidence of leadership in their company. Key insiders include executive officers and board members.
| Name | Position | Shares Owned | Percentage of Ownership |
|---|---|---|---|
| John Adent | CEO | 500,000 | 1.2% |
| James Herbert | Chairman | 400,000 | 1.0% |
| Christine B. Knauss | CFO | 300,000 | 0.75% |
| Pedro L. Arrieta | COO | 300,000 | 0.75% |
| Linda L. Kauffman | Board Member | 200,000 | 0.5% |
Market Performance
Neogen Corporation’s market capitalization and performance metrics indicate its financial standing. As of the latest data:
- Current Stock Price: $28.95
- Market Capitalization: $1.5 billion
- 52-Week Range: $22.67 - $31.34
- Average Daily Volume: 250,000 shares
- P/E Ratio: 40.2
Recent Developments Regarding Ownership
Recent trends indicate an increase in institutional ownership as the company positions itself for future growth. Notable recent changes include:
- Increase in Vanguard Group's stake: Up by 2.5% in the last quarter.
- BlackRock's recent purchase: An additional 300,000 shares acquired.
- Insider selling activity: 50,000 shares sold by the CFO.
Conclusion
This chapter presents a detailed examination of the ownership structure of Neogen Corporation, focusing on the types of shareholders, their percentages, and the financial implications of their holdings.
Neogen Corporation (NEOG) Mission Statement
Overview of Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, is a leading company specialized in developing and marketing solutions for food and animal safety. Founded in 1982, Neogen aims to provide products that ensure the safety and quality of food and animal health.
Mission Statement
The mission statement of Neogen Corporation centers around the commitment to "safeguarding the world's food supply and improving the health of animals." Their core belief is to leverage science and innovation to create products that enhance food safety and animal health.
Key Aspects of the Mission Statement
- Commitment to Safety: Ensuring safety in food production and animal health.
- Innovation: Continuous development of new products and solutions.
- Global Reach: Serving clients across more than 110 countries.
- Customer Focus: Delivering quality products to meet diverse customer needs.
Financial Overview
As of the fiscal year ending May 31, 2023, Neogen Corporation reported:
| Financial Metric | Amount (in Millions USD) |
|---|---|
| Revenue | 515.3 |
| Gross Profit | 261.2 |
| Net Income | 58.4 |
| Total Assets | 799.5 |
| Total Liabilities | 307.0 |
Business Segments
Neogen operates through various business segments, primarily focusing on:
- Food Safety: Products that ensure the safety of food products at all stages of processing.
- Animal Safety: Solutions that enhance the health and welfare of livestock and companion animals.
- Pharmaceuticals: Development of veterinary pharmaceuticals and health products.
Recent Developments
In 2023, Neogen launched several new products as part of its mission to enhance food safety:
- New Rapid Test Kits: Developed for pathogen detection.
- Enhancements in Animal Health: Advanced diagnostics for livestock.
Market Presence
Neogen has a significant market presence illustrated by:
| Region | Revenue Contribution (%) |
|---|---|
| North America | 55 |
| Europe | 25 |
| Asia-Pacific | 15 |
| Latin America | 5 |
Strategic Goals
Neogen's strategic goals align with its mission statement and include:
- Expand Product Portfolio: Focused on enhancing the range of food and animal safety products.
- Increase Market Penetration: Targeting new geographical regions for growth.
- Enhance R&D Investments: Committed to increasing investment in research and development.
How Neogen Corporation (NEOG) Works
Business Overview
Business Overview
Neogen Corporation (NEOG) specializes in developing products dedicated to food and animal safety. The company operates primarily through two segments: Food Safety and Animal Safety.
Market Position and Reach
As of 2023, Neogen has a presence in over 110 countries, with its products being utilized in industries ranging from agriculture to pharmaceuticals.
Financial Performance
In the fiscal year 2023, Neogen reported a revenue of approximately $490 million, reflecting a year-over-year growth rate of 12%.
| Fiscal Year | Revenue (in $ million) | Net Income (in $ million) | EPS (Earnings Per Share) |
|---|---|---|---|
| 2023 | 490 | 30 | 0.47 |
| 2022 | 436 | 28 | 0.44 |
| 2021 | 384 | 25 | 0.40 |
Product Offerings
Neogen’s product lineup includes:
- Food Safety Tests
- Biosecurity Products
- Diagnostic Tests for Animal Health
- Pest Control Solutions
- Hygiene Products
Research and Development
The company invests heavily in R&D, allocating around 10% of its annual revenue to innovate and enhance its product offerings.
Global Workforce
Neogen employs approximately 1,500 people globally, contributing to its high operational capacity and product development speed.
Acquisitions and Growth Strategy
In the past five years, Neogen has acquired several companies to strengthen its portfolio, including:
- Hygiena, LLC (acquired in 2021 for approx. $90 million)
- GeneSeek (acquired in 2020)
- Flock Free (acquired in 2019)
Environmental, Social, and Governance (ESG) Initiatives
Neogen is committed to sustainability, demonstrated by its aim to reduce waste by 25% by 2025 and its active involvement in community service programs.
Stock Performance
As of the end of Q3 2023, Neogen’s stock (NEOG) traded at approximately $27.30, with a market capitalization of around $1.75 billion.
Competitive Landscape
Primary competitors include:
- Thermo Fisher Scientific
- Merck KGaA
- SGS SA
Future Outlook
The company anticipates a growth rate of 10% annually over the next five years, driven by increased demand for food safety and animal health products.
How Neogen Corporation (NEOG) Makes Money
Revenue Streams
Neogen Corporation generates revenue primarily through two main segments: Food Safety and Animal Safety. In the fiscal year 2023, Neogen reported total revenue of $513.2 million, with the following breakdown:
| Segment | Revenue (in millions) | Percentage of Total Revenue |
|---|---|---|
| Food Safety | $291.4 | 56.8% |
| Animal Safety | $221.8 | 43.2% |
Food Safety Segment
The Food Safety segment includes products that test for pathogens, allergens, and toxins in food and beverage products. Major product lines in this segment consist of:
- Tests for pathogens such as Salmonella, Listeria, and E. coli
- Allergen testing kits
- Sanitation products
- Quality control products
In fiscal 2023, this segment experienced a growth rate of 7.5% year-over-year, driven by increased demand for food safety testing due to regulatory pressures and rising consumer awareness.
Animal Safety Segment
The Animal Safety segment encompasses a wide range of products designed for animal health, including:
- Diagnostics for animal diseases
- Pharmaceuticals for livestock and pets
- Veterinary instruments
- Biosecurity products
In fiscal 2023, revenue from the Animal Safety segment increased by 4.3% compared to the previous year, reaching $221.8 million.
Geographical Breakdown
Neogen's revenue is generated from various geographical markets, with the United States being the largest contributor. The geographical revenue distribution for fiscal year 2023 is as follows:
| Region | Revenue (in millions) | Percentage of Total Revenue |
|---|---|---|
| United States | $368.5 | 71.8% |
| International | $144.7 | 28.2% |
Research and Development
Neogen invests heavily in research and development to maintain its competitive edge. In fiscal year 2023, Neogen allocated approximately $38 million to R&D, representing around 7.4% of total revenue. This investment focuses on:
- Innovating new testing products
- Enhancing existing product offerings
- Improving animal health solutions
Recent Acquisitions
Neogen has strategically acquired companies to expand its market reach and product offerings. In 2022, Neogen acquired 3M’s Food Safety Business for approximately $1.3 billion, which significantly bolstered its portfolio in food safety testing.
Market Position
Neogen holds a strong position within the food and animal safety sectors. As of 2023, it ranks among the top three companies worldwide in food safety testing and diagnostics, with a market share of approximately 15%.
Financial Performance
For the fiscal year ending May 31, 2023, Neogen reported the following financial highlights:
| Metric | Amount |
|---|---|
| Total Revenue | $513.2 million |
| Net Income | $51.5 million |
| Earnings Per Share (EPS) | $0.68 |
| Operating Margin | 12.2% |
| Current Ratio | 2.5 |
Neogen Corporation (NEOG) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support